Instem

Instem

World-leading information solutions provider for life sciences r&d their software applications accelerate drug and chemical.

Launch date
Employees
Market cap
$250m
Enterprise valuation
$241m (Public information from Nov 2023)
Conshohocken Pennsylvania (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
GBP2019202020212022
Revenues25.7m28.2m46.0m58.9m
% growth-10 %63 %28 %
EBITDA1.5m5.4m8.3m11.6m
% EBITDA margin6 %19 %18 %20 %
Profit(<1m)2.3m1.7m4.7m
% profit margin(4 %)8 %4 %8 %
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
*
N/A

€2.5m

Grant
*

£203m

Valuation: £203m

3.4x EV/LTM Revenues

17.5x EV/LTM EBITDA

Acquisition
Total Funding$2.8m

Recent News about Instem

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Instem

Edit
BioWisdom
ACQUISITION by Instem Mar 2011
Logos Technologies
ACQUISITION by Instem May 2013
NOTOCORD
ACQUISITION by Instem Sep 2016
D-Wise Technologies
ACQUISITION by Instem Mar 2021
Leadscope
ACQUISITION by Instem Nov 2019
The Edge Software Consultancy
ACQUISITION by Instem Mar 2021
Samarind
ACQUISITION by Instem May 2016
Pds Life Sciences
ACQUISITION by Instem Sep 2021